Literature DB >> 12441916

Deep vein and isolated calf muscle vein thrombosis following long-haul flights: pilot study.

T Schwarz1, K Langenberg, W Oettler, K Halbritter, J Beyer, G Siegert, S Gehrisch, H E Schroeder, S M Schellong.   

Abstract

The risk of venous thromboembolism associated with long-haul flights is the subject of controversy. In a prospective, controlled study, we examined 160 passengers before and after return from a long-haul flight and 160 age-matched and sex-matched, non-travelling volunteers using venous compression ultrasound. Deep vein thrombosis was not observed in either group. Isolated calf muscle vein thrombosis (ICMVT) was present in 4/160 (2.5%) flight passengers and in 1/160 (0.6%) controls. All subjects with ICMVT were clinically asymptomatic, and ICMVT was located in the soleal muscle veins in all four subjects. Three of the four passengers with ICMVT had other risk factors for thrombosis.

Entities:  

Mesh:

Year:  2002        PMID: 12441916     DOI: 10.1097/00001721-200212000-00013

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  Elderly patients with intertrochanteric fractures after intramedullary fixation : Analysis of risk factors for calf muscular vein thrombosis.

Authors:  Hao Su; Hongzhi Liu; Juan Liu; Xin Wang
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

2.  Jobs encompassing prolonged sitting in cramped positions and risk of venous thromboembolism: cohort study.

Authors:  Poul Suadicani; Harald Hannerz; Elsa Bach; Finn Gyntelberg
Journal:  JRSM Short Rep       Date:  2012-02-14

Review 3.  Air travel and venous thromboembolism: a systematic review.

Authors:  John T Philbrick; Rebecca Shumate; Mir S Siadaty; Daniel M Becker
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

4.  COVID-19, long flights, and deep vein thrombosis: What we know so far.

Authors:  Zbigniew Krasiński; Andre Chou; Hubert Stępak
Journal:  Cardiol J       Date:  2021-08-06       Impact factor: 2.737

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.